Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Respir Physiol ; 127(1): 3-11, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11445196

RESUMO

The respiratory effects of acute spinal injury and paralysis are difficult to study. Urgent medical needs of human spinal cord injury victims usually preclude study, while induction of spinal cord lesions in awake animals is not feasible ethically. We utilized controlled, segmental infusion of epidural anesthetic in awake, highly trained, implanted canines to reversibly simulate the effects of thoracic and cervical (paraplegic and quadriplegic) spinal cord injury. We studied six animals, an average of 29 days after implantation with electromyogram and sonomicrometry transducers in transversus abdominis, external intercostal, parasternal intercostal and costal diaphragm muscles. Anesthetic was infused through an epidural catheter inserted percutaneously, under fluoroscopic guidance. Asymmetrical motor blockade was prevented using repositioning during epidural infusions. By sequential infusion we were able to induce three distinct, functional levels of spinal paralysis showing cumulative paralysis of abdominal, external intercostal, and parasternal intercostal muscles. Paralysis of the abdomen and chest wall, sparing only the diaphragm, showed unexpected bradypnea and failure to maintain minute ventilation.


Assuntos
Modelos Animais de Doenças , Cães , Respiração , Traumatismos da Medula Espinal/fisiopatologia , Doença Aguda , Anestesia Epidural , Animais , Conscientização , Cateterismo , Eletromiografia , Fluoroscopia , Masculino , Paraplegia/fisiopatologia , Quadriplegia/fisiopatologia , Paralisia Respiratória/fisiopatologia
2.
J Pediatr Hematol Oncol ; 23(1): 54-6, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11196272

RESUMO

A 14-year-old boy with longstanding multisystem Langerhans cell histiocytosis (LCH) had multifocal bone pain unresponsive to chemotherapy, corticosteroids, anti-inflammatories, and narcotic analgesics. He responded to two cycles of intravenous pamidronate, each 90 mg per day on three consecutive days. Two subsequent episodes of deterioration also responded to treatment. The pathophysiology of his bone pain and the likely mechanisms of biphosphonate action are discussed, with emphasis on the molecular and cellular basis of LCH.


Assuntos
Anti-Inflamatórios/uso terapêutico , Difosfonatos/uso terapêutico , Histiocitose de Células de Langerhans/tratamento farmacológico , Adolescente , Histiocitose de Células de Langerhans/fisiopatologia , Humanos , Masculino , Pamidronato
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...